MARKET

IMRN

IMRN

Immuron Ltd
NASDAQ
1.510
-0.050
-3.21%
After Hours: 1.505 -0.006 -0.36% 19:37 12/05 EST
OPEN
1.540
PREV CLOSE
1.560
HIGH
1.540
LOW
1.430
VOLUME
279.40K
TURNOVER
--
52 WEEK HIGH
2.483
52 WEEK LOW
1.420
MARKET CAP
10.49M
P/E (TTM)
-2.5421
1D
5D
1M
3M
1Y
5Y
1D
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 3d ago
Trump Trade: Trump administration to take stake in xLight
TipRanks · 3d ago
BRIEF-Immuron New U.S. Department Of Defense Award & Clinical Trial Update
Reuters · 3d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 3d ago
Immuron anounces new DoD award and clinical trial updates
TipRanks · 3d ago
Immuron Announces A New Research Agreement With The Naval Medical Research Command And The Walter Reed Army Institute Of Research, Funded By U.S. Department Of Defense Subaward
Benzinga · 3d ago
Immuron and U.S. Military Secure Department of Defense Grant to Develop Oral Therapeutics for Campylobacter and Shigella
Reuters · 3d ago
More
About IMRN
Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), and IMM-529.

Webull offers Immuron Ltd - ADR stock information, including NASDAQ: IMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMRN stock methods without spending real money on the virtual paper trading platform.